F352-0009 Screening compound: 1-cyclobutanecarbonyl-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]

F352-0009 Screening compound: 1-cyclobutanecarbonyl-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]
F352-0009 Screening compound: 1-cyclobutanecarbonyl-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline] alternative view

Chemical Structure Depiction of ChemDiv screening compound F352-0009
1-cyclobutanecarbonyl-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F352-0009

Molecular Formula

C20H23N3O (C20 H23 N3 O)

Compound Name

1-cyclobutanecarbonyl-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]

IUPAC name

1-cyclobutanecarbonyl-5'H-spiro[piperidine-44'-pyrrolo[12-a]quinoxaline]

SMILES

O=C(C1CCC1)N(CC1)CCC11Nc(cccc2)c2-n2c1ccc2

InChI

InChI=1S/C20H23N3O/c24-19(15-5-3-6-15)22-13-10-20(11-14-22)18-9-4-12-23(18)17-8-2-1-7-16(17)21-20/h1-2,4,7-9,12,15,21H,3,5-6,10-11,13-14H2

InChI Key

PGFIBEMSFAYFDK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27641928

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

321.42

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.130

Distribution Coefficient, logD

3.129

Water Solubility, LogSw

-3.24

Polar Surface Area

30.917

Acid Dissociation Constant (pKa)

19.44

Base Dissociation Constant (pKb)

8.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.00

F352-0009 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with F352-0009 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F352-0009?
Check Price and Availability of F352-0009, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F352-0009 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F352-0009
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F352-0009
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F352-0009 available by request